You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
About This Series
Infection with the bacterium Neisseria meningitidis can cause serious, life-threatening illness. Six serogroups are responsible for the majority of meningococcal disease worldwide, with serogroup B being most problematic in high-income countries. In recent years, 2 vaccines have become available to prevent serogroup B meningococcal disease. The importance of preventing meningococcal disease in infants is widely recognized. This program highlights the importance of considering vaccination for another population at risk: adolescents and young adults.
Infection with the bacterium Neisseria meningitidis can cause serious, life-threatening illness. Six serogroups are responsible for the majority of meningococcal disease worldwide, with serogroup B being most problematic in high-income countries. In recent years, 2 vaccines have become available to prevent serogroup B meningococcal disease. The importance of preventing meningococcal disease in infants is widely recognized. This program highlights the importance of considering vaccination for another population at risk: adolescents and young adults.
Host
Kevan H. Chambers, CBiol, MRSB
MEDEGY Science & Healthcare Co., St. Petersburg, Florida
Faculty
Carlo Signorelli, MD, MSc, PhD
Full Professor, Hygiene and Public Health, University of Parma, Vita-Salute San Raffaele University, Milan, Italy
Federico Martinón-Torres, MD, PhD
Head, Translational Pediatrics and Infectious Diseases Section, Pediatrics Department, Hospital Clinico Universitario de Santiago de Compostela; Coordinator, Genetics Vaccines Infections and Pediatrics Research Group (GENVIP), Healthcare Research Institute of Santiago de Compostela, Santiago de Compostela, Spain
George Kassianos, MD
General Practitioner, Bracknell, United Kingdom